Drug stocks edge higher; Genzyme gains

ValBrickates Kennedy

BOSTON (MarketWatch) -- Drug stocks inched higher early Wednesday as shares of Genzyme Corp.
genz
gained ground after it released a fourth-quarter financial report that topped many Wall Street estimates. The NYSE Arca Pharmaceutical Index
$drg
rose 0.5% to 306.06 and the NYSE Arca Biotechnology Index
$brk
was up nominally at 1010.82. Shares of Genzyme were up 1% at $55.90.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information.
All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.